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The bioassay-guided fractionation of the n-hexane extract of Citrus reticulata Blanco 
(Rutaceae) stem bark yielded scoparone (1), xanthyletin (2), lupeol (3), β-amyrin (4), 
stigmasterol (5), β-sitosterol (6) and palmitic acid. The structures of these compounds were 
determined by comprehensive spectroscopic analyses, i.e., 1D and 2D NMR and EI-MS, and 
by comparison with the reported data. Extracts, fractions and isolated compounds 1-6 were 
assessed for cytotoxicity by the MTT assay against three human cancer cell lines, i.e., human 
lung adenocarcinoma cell line A549, human breast adenocarcinoma cell line MCF7 and 
human Caucasian prostate adenocarcinoma cell line PC3. Significant activity of the n-hexane 
and the dichloromethane extracts was observed against the breast cancer cell line MCF7 with 
IC50s of 45.6 and 54.7 μg/mL, respectively. Moreover, the 70% ethyl acetate in n-hexane 
chromatographic fraction showed significant activity displaying IC50 values of 53.0, 52.4 and 
49.1 μg/mL against the cancer cell lines A549, MCF7 and PC3, respectively. Encouragingly, 
an IC50 of 510.0 µg/mL against the human normal prostate cell line PNT2 indicated very low 
toxicity, and hence favourable selectivity indices for the 70% ethyl acetate in n-hexane 
fraction in the range of 9.6-10.4 towards cell lines A549, MCF7 and PC3. Since compounds 
isolated from the above fraction only delivered IC50 values in the range of 18.2-96.3, 9.2-34.1 
and 7.5-97.2 μg/mL against A549, MCF7 and PC3 cell lines, respectively, synergistic action 
between compounds is suggested. Bioassay results valorize the anticancer effectivity of the 









Citrus reticulata Blanco (Rutaceae) or mandarin originates from China and was introduced to 
Africa and Europe via the Northern African route between the fifteenth and nineteenth 
century through trade with Portuguese and British Asian colonies (Ramón-Laca et al., 2003). 
In Cameroon, the plant conquered all habitats and can nowadays even be found disseminated 
in the Cameroonian rainforest. The medicinal potential of its bark against tumours had been 
recognized early on by medicinal practioners.  
Since fruits of Citrus species are used worldwide in traditional medicine for a wide range of 
conditions, including cancer prevention, treatment of flu, inflammation and more generally in 
healing and strengthening of the body, their pharmacological potential had been widely 
investigated during recent decades, resulting in hundreds of publications. The hydroxylated 
polymethoxyflavones 5-hydroxy-6,7,8,3’4’-pentamethoxyflavone and 5-hydroxy-
3,6,7,8,3’4’-hexaamethoxyflavone isolated from the peel display strong inhibitory activity 
against the proliferation of the human promyelocytic leukaemia cell line HL60 and induce 
apoptosis (Li et al., 2007). Hesperidin, also isolated from the peel, showed pronounced 
activity against larynx, breast and liver carcinoma cell lines (Al-Ashaal and El-Sheltawy, 
2011). Inhibition of human lung cancer cell lines H1299, H441 and H460 and induction of 
apoptosis was reported for nobiletin, 3,5,6,7,8,3’,4’-heptamethoxyflavone and 5-hydroxy-
3,7,8,3’,4’-pentamethoxyflavone isolated from a peel extract (Xiao et al., 2009). Limonin and 
naringin produced by Citrus fruits displayed bone calcium concentration preservation and 
increased the antioxidant status in animal model (Mandadi et al., 2009). 
Conversely however, very little is known about the pharmacological potential of secondary 
metabolites produced by seeds, leaves, roots and the bark of the Citrus species. In our 
ongoing investigation of the medical potential of plants of the Rutaceae family, several 
compounds isolated from the roots of C. reticulata have been reported to display strong 
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oxidative burst inhibition and suppression of the phagocytosis response upon activation with 
serum opsonized zymosan in the range of 0.2-10.5 μM (Fomani et al., 2016). In continuation 
of our research on C. reticulata, this paper deals with the isolation, structure elucidation and 
pharmacological evaluation of secondary metabolites produced by its stem bark. 
Materials and methods 
General experimental procedures 
Ultraviolet spectra were recorded on a Hitachi UV 3200 spectrophotometer in MeOH. 
Infrared spectra were recorded on a JASCO 302-A spectrophotometer. EI-MS were recorded 
on a Finnigan MAT 95 spectrometer (70 eV) with perfluorokerosene as reference substance 
for EI-HR-MS. The 1H- and 13C-NMR spectra were recorded at 600 MHz and 150 MHz, 
respectively on Bruker AMX 600 NMR spectrometers. Methyl, methylene and methane 
carbons were distinguished by DEPT experiments. Homonuclear 1H connectivities were 
determined by using the COSY experiment. 1H-13C one-bond connectivities were determined 
with HSQC gradient pulse factor selection. Two- and three-bond connectivities were 
determined by HMBC experiments. Chemical shifts are reported in δ (ppm) using TMS as 
internal standard and coupling constants (J) were measured in Hz. Column chromatography 
was carried out on silica gel (70-230 mesh, Merck). Thin Layer Chromatography (TLC) was 
performed on Merck precoated silica gel 60 F254 aluminium foil, and spots were detected 
using ceric sulphate spray reagent. Phenolic compounds were detected using FeCl3 reagent. 
The purity of the compounds was investigated by means of 1H-NMR and ESIMS. The degree 
of purity of the positive control was ≥ 98%, while that of the isolated compounds was 95%. 
Unless otherwise stated, all chemicals were purchased from Sigma-Aldrich (Dorset, UK). 
Solvents were purchased from Fischer Scientific (Loughborough, UK). All cell culture 
reagents were purchased from Labtech International Ltd (East Sussex, UK). The human lung 
adenocarcinoma cell line A549, human breast adenocarcinoma cell line MCF7 and human 
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Caucasian prostate adenocarcinoma cell line PC3 were purchased from the American Type 
Culture Collection (ATCC), 10801 University Blvd., Manassas, USA. The normal human 
prostate cell line PNT2 was obtained from the European Collection of Authenticated cell 
cultures (ECACC), (Salisbury, UK). All reagents used were of analytical grade.   
Plant material 
Bark of C. reticulata was collected at the Batouri locality in Eastern Cameroon in December 
2015 and identified by Mr. Nana Victor of the National Herbarium, Yaoundé, Cameroon, 
where a voucher specimen (25856SRF/Cam) was deposited. 
Extraction and bioassay guided isolation 
Soxhlet extraction of 1.2 kg of the air dried and powdered bark of C. reticulata yielded - after 
evaporation under reduced pressure - 19.3, 25.4 and 38.2 g of n-hexane (Hex), 
dichloromethane (DCM) and methanol (MeOH) extract. Soxhlet extraction for each solvent 
was continued for ten cycles. The extracts were submitted to the 3-(4,5-dimethylthiazol-2-yl)-
2,5-dphenyltetrazolium bromide (MTT) cytotoxicity/viability assay employing human cancer 
cell lines A549, MCF7, PC3 and  normal cell PNT2. Tests were run in triplicate and activities 
compared to the positive control etoposide, a semi-synthetic derivative of podophyllotoxin, a 
compound originating from the roots of Podophyllum peltatum (Berberidaceae). The Hex 
extract was found to be the most active against all three cancer cell lines and thus subjected to 
Vacuum Liquid Chromatography (VLC) on TLC grade silica gel as the stationary phase. 
Elution was performed with mixtures of n-hexane and ethyl acetate (EA), namely 20% of EA 
in Hex, 50% of EA in Hex and 70% of EA in Hex to give three fractions, which were 
collected and evaporated under reduced pressure to obtain 2.5, 6.3 and 8.2 g, respectively. 
Subsequent MTT assays showed best results for the 70% of EA in Hex fraction, which was 
then submitted to column chromatography over silica gel 60 (230-400 mesh, 3.5 x 3.5 cm) 
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using a gradient system of n-hexane and CH2Cl2. A total of 53 sub-fractions (ca. 100 mL 
each) were collected and pooled on the basis of TLC analysis leading to three series (A-C). 
Fraction A [1.5 g, combination of sub-fractions 1-15, eluted with a mixture of n-hexane-
CH2Cl2 (4:1)] yielded palmitic acid (18.2 mg) and lupeol (3) (21.5 mg), while fraction B [2.6 
g, constituted by sub-fractions 16-31, eluted with a mixture of n-hexane-CH2Cl2 (3:2)] led to 
β-amyrin (4) (11.2 mg), stigmasterol (5) (15.3 mg) and β-sitosterol (6) (16.4 mg). Fraction C 
[3.1 g, combination of sub-fractions 31-53, eluted with n-hexane-CH2Cl2 (1:1) to 100% 
CH2Cl2] gave scoparone (1) (15.5 mg) and xanthyletin (2) (8.1 mg) (Fig. 1). Finally, 
compounds 1-6 were submitted to the MTT assay, and bioactivity results evaluated together 
with those previously received from crude extracts and fractions, in comparison to the 
positive control etoposide. 
Scoparone (1): (Afek and Sztejnberg, 1988).  
Xanthyletin (2): (Tillekeratne et al., 1989). 
Lupeol (3): (Fomani et al., 2016). 
β-amyrin (4): (Longue et al., 2015). 
Stigmasterol (5): (Fomani et al., 2016). 
β-sitosterol (6): (Fomani et al., 2016). 
Cell lines, cell cultures and the MTT assay     
The potential cytotoxicity of Citrus reticulata stem bark extracts, their VLC fractions and the 
isolated compounds were studied against cancer cell lines A549 (human lung 
adenocarcinoma), MCF7 (human breast adenocarcinoma), PC3 (human prostate 
adenocarcinoma) and the normal cell line PNT2 (human prostate) using the MTT assay 
(Mosmann, 1983; Basar et al., 2015). All cell lines were cultured in RPMI-1640 medium 
supplemented with 10% foetal bovine serum and 1% antibiotic-antimycotic solution (100 x). 
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The cells were cultured at 37 °C in 95% humidity and 5% CO2. For the MTT assays, the cells 
were washed using phosphate buffered saline and harvested by trypsinization. Cells were 
then seeded into 24 well plates at a density of 1.2 x 104 cells/well in a working volume of 1 
mL/well and allowed to grow for 24h before the commencement of each experiment. The 
cells were then treated for 24h with different concentrations of test samples (the C. reticulata 
extracts and VLC fractions at 0, 0.8, 4, 20, 100, 500 μg/mL and the compounds at 0, 0.4, 2, 
10, 50, 75 and 100 μg/mL). Dilution of stock solutions was made in culture medium yielding 
final sample concentrations with a final dimethyl sulfoxide (DMSO) concentration of 0.1%, 
including the control. Each sample concentration was used to treat four wells of cells in each 
24-well plate. After the 24h treatment period, the toxicity of the samples on each cell line was 
quantified. To achieve this, the medium in each well was replaced by MTT solution (500 
μg/mL in medium) and incubated for 2h. Viability of cells was assessed by their ability to 
reduce the yellow dye MTT to a blue formazan product (Popescu et al., 2015). The MTT 
reagent was removed, the formazan crystals were dissolved in isopropanol, and the 
absorbance at 560 nm determined using a microplate reader (CLARIO Star Microplate 
Reader, BMG Labtech, UK). The average absorbance value obtained from zero treatment 
control (0.1% DMSO) wells was arbitrarily set at 100% for each plate, and the absorbance 
value for the average of wells of cells treated with each test sample concentration was 
expressed as a percentage of this control. Each assay was performed on a minimum of three 
separate occasions, and the IC50 values for each sample on each cell line were calculated 





All experiments were carried out in triplicate on separate occasions. Data were expressed as 
means ± standard error of the mean. The graphs were plotted using nonlinear regression with 
the use of Microsoft Excel version 2013. 
Results and discussion     
Soxhlet extraction of 1.2 kg of bark material of C. reticulata Blanco led - after evaporation 
under vacuum - to 19.32 g of Hex, 25.45 g of DCM and 38.16 g of MeOH extract. These 
extracts were tested against cancer cell lines A549, MCF7 and PC3, and normal cell line 
PNT2 using the MTT assay. Etoposide was used as positive control. While the MeOH extract 
was found to be inactive against above cancer cell lines, displaying IC50 values > 500 μg/mL, 
the DCM extract showed IC50 values of (A549) 220.5, (MCF7) 54.7 and (PC3) 220.2 μg/mL, 
respectively. The Hex extract was the most active with IC50 values of (A549) 100.2, (MCF7) 
45.6 and (PC3) 100.5 μg/mL and was selected for fractionation by VLC technique. Three 
fractions, namely 20% of EA in Hex, 50% of EA in Hex and 70% of EA in Hex were 
obtained and submitted to MTT assay. The 20% of EA in Hex fraction resulted in IC50 values 
of (A549) 210.3, (MCF7) 210.1 and (PC3) 445.4 μg/mL; the 50% fraction in (A549) 70.1, 
(MCF7) 205.5 and (PC3) 49.4 μg/mL and, most interestingly, the 70% of EA in Hex fraction 
in IC50 values of (A549) 53.0, (MCF7) 52.4 and (A549) 49.1 μg/mL. The positive control 
etoposide delivered IC50 values of (A549) 3.5, (MCF7) 10.2 and (PC3) 7.9 μg/mL, while the 
negative control consisting of media with DMSO did not display activity as was expected. It 
should be noted that the 70% of EA in Hex fraction is only 5-15 fold less active than the 
anticancer drug etoposide, depending on the cell line tested (Table 1; Figs. 2a-f, supporting 
information). 
In the following, the 70% EA in Hex fraction was subjected to column chromatography on 
silica gel and preparative TLC to afford seven known compounds identified as scoparone (1), 
xanthyletin (2), lupeol (3), β-amyrin (4), stigmasterol (5), β-sitosterol (6) and palmitic acid. 
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The structures of compounds were determined by comprehensive spectroscopic analyses (1D 
and 2D NMR and EI-MS) and by comparison with reported data. Other than expected, 
compounds isolated from the 70% EA in Hex fraction delivered moderate to low activities in 
MTT assay: while scoparone (1) gave IC50 values of 18.2, 20.3 and 18.7 μg/mL against cell 
line A549, MCF7 and PC3, respectively, stigmasterol (5) showed values of 21.1, 9.2 and 7.5 
μg/mL, respectively. The latter values were comparable to those reported previously with 
20.0, 8.8 and 7.8 μg/mL, respectively (Malek et al., 2009; Hsu et al., 2011; Shen et al., 2012). 
In addition, lupeol (3) displayed IC50 values of 21.0, 32.1 and 30.1 μg/mL against cell line 
A549, MCF7 and PC3, respectively, and β-amyrin (4) and xanthyletin (2) were moderately to 
low active with IC50 values of 74.2, 34.1, 70.1 and 80.1, 19.3, 97.2 μg/mL, respectively. 
Finally, β-sitosterol (6) displayed low activity with IC50 of 96.3 µg/mL against cell line A549 
and was shown to be not active against cell line MCF7 and PC3 displaying IC50 values > 250 
µg/mL corresponding well to IC50 values of 87 µg/mL against cell line A549 and 72 µg/mL 
against cell line PC3 reported previously (Malek et al., 2009) (Table 2; Figs. 2a-f, supporting 
information). 
A comparison of IC50 values of crude extracts, fractions and isolated compounds clearly 
shows that the 70% EA in Hex fraction not only displays significant activities against cell 
lines A549, MCF7 and PC3, but is only around 3 times less active than scoparone (1) and 
stigmasterol (5), the two most active compounds reported here from this fraction. While the 
70% EA in Hex fraction is in addition only 6 times less active than positive control etoposide 
against human prostate cancer cell line PC3 this fraction displayed low toxicity against the 
human normal prostate cell line PNT2 with IC50 = 510.0 µg/mL, resulting in very favourable 
selectivity indices of 9.6, 9.7 and 10.4 µg/mL towards cell lines A549, MCF7 and PC3, 
respectively (Table 3). 
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It should be mentioned that in natural products chemistry and pharmacology, a medicinal 
plant extract displaying inhibitory activity of IC50 < 500 μg/mL is regarded as active, and IC50 
values of 300-400 μg/mL characterise an extract worth to identify its active ingredients. 
Interestingly, IC50 values around 50 μg/mL determined for the 70% EA in Hex fraction 
combined with moderate to low activities in the IC50 range of 7.5-97.2 μg/mL measured for 
secondary metabolites present in this fraction, strongly indicate synergistic effects. 
 Etoposide is used as one of the drugs of choice in the treatment of human lung 
adenocarcinoma and was shown here to give an IC50 of 3.5 μg/mL against human lung cancer 
cell line A549, compared to the 70% EA in Hex fraction, 50% EA in Hex fraction and the 
hexane crude extract from the stem bark of C. reticulata showing IC50 values of 53.0, 70.1 
and 100.2 μg/mL, respectively. 
Conclusions  
In vitro assays show that the stem bark of C. reticulata widely used in Cameroon against 
tumours is probably a good crude drug treatment against lung, breast and prostate cancer 
when extracted with hexane and in addition against breast cancer when extracted with 
dichloromethane. Moreover, first assays display very low toxicity of a hexane extract fraction 
against a human normal prostate cell line. However, additional in vitro and in vivo toxicity 
testing will be necessary, before a recommendation of above preparations can be given. A 
positive outcome might initiate formulation studies for the development of a safer anticancer 
plant product from the stem bark of this plant, to be manufactured in developing countries. 
While the anti-lung cancer drug etoposide is mostly given in combination therapy to reduce 
the therapeutical dosis, it is suggested that the 70% ethyl acetate in hexane fraction from the 
stem bark of C. reticulata might turn out to be a candidate for supplemental treatment, subject 
to further investigation of its overall synergistic and biochemical mechanisms of action 
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Table 1. IC50 values of Hex, DCM and MeOH extracts and EA in Hex fractions of Citrus 
reticulata stem bark for cell lines A549, MCF7 and PC3 
 
Sample Extract IC 50 in μg/mL 
 
 A549 MCF7 PC3 
Hex 100.2 ± 3.2 45.6 ± 1.2 100.5 ± 4.5 
DCM 220.5 ± 2.4 54.7 ± 3.1 220.2 ± 1.8 
MeOH > 500 > 500 > 500 
20% EA in Hex 210.3 ± 5.5 210.1 ± 3.6 445.4 ± 4.4 
50% EA in Hex 70.1 ± 1.5 205.5 ± 2.5 49.4 ± 5.7 
70% EA in Hex 53.0 ± 3.4 52.4 ± 3.6 49.1 ± 1.9 




Table 2.  IC50 values of compounds isolated from Citrus reticulata stem bark for cell lines 
A549, MCF7 and PC3 
 
Compounds IC 50 in μg/mL 
 
A549 MCF7 PC3 
1 18.2 ± 4.2 20.3 ± 1.2 18.7 ± 1.5 
2 80.1 ± 4.1 19.3 ± 3.8 97.2 ± 4.0 
3 
21.0 ±7.4 32.1  ±11.2 30.1 ±5.3 
4 
74.2 ±2.2 34.1 ±1.9 70.1 ±2.4 
5 21.1 ± 0.7 9.2 ±0.9 7.5 ±1.1 
6 96.3 ±2.1 >250 >250 









Table 3. IC50 values of the 70% EA in Hex fraction of Citrus reticulata stem bark for 
human cancer cell lines A549, MCF7 and PC3 and selectivity indices related to human 
normal prostate cell line PNT2 
 
Cell line IC50  in µg/mL Selectivity index =  
IC50 of human normal cell 
line / IC50  of human 
cancer cell line 
             Cancer cell line A549 53.0 9.6 
            Cancer cell line MCF7 52.4 9.7 
              Cancer cell line PC3 49.1 10.4 
            Normal cell line PNT2 510.0 - 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
